Literature DB >> 9034223

Extrahepatic ischemia-reperfusion injury reduces hepatic oxidative drug metabolism as determined by serial antipyrine clearance.

B J Gurley1, G W Barone, K Yamashita, S Polston, M Estes, A Harden.   

Abstract

PURPOSE: All transplanted solid organs experience some degree of ischemia-reperfusion (I-R) injury. This I-R injury can contribute to graft dysfunction which stems in part from the acute phase response and a resultant host of cytokines. Recent evidence suggests that organs remote to the site of I-R injury can be affected by circulating cytokines originating from these I-R injuries. Since many of these acute phase cytokines inhibit hepatic cytochrome P-450 (CYP) enzymes, we chose to investigate whether extrahepatic I-R injuries could influence hepatic oxidative drug metabolism.
METHODS: Fifteen dogs were divided into three surgical groups: (I) sham I-R; (II) bilateral normothermic renal I-R; and (III) normothermic intestinal I-R. Antipyrine (AP) was selected as a model substrate and administered intravenously at a dose of 10 mg/kg. AP serum concentrations were determined by HPLC and cytokine activity (IL-1, IL-6, and TNFalpha) was measured via bioassay. Serial AP clearance and serum cytokine concentrations were determined 3 days prior to and at 4 hr, 24 hr, 3 days and 7 days after surgery. Hematology and blood chemistries were monitored throughout the study period.
RESULTS: AP clearance was significantly reduced in groups II and III at 4 and 24 hrs post-l-R injury, while AP binding and apparent volume of distribution were unaffected. Peak levels of TNF and IL-6 activity occurred at 1 and 4 hours, respectively. IL-I activity was not detected in any group. AP clearance correlated strongly to circulating levels of IL-6 (r = -0.789, p = 0.0002).
CONCLUSIONS: Our findings indicate that extrahepatic I-R injury can affect hepatic oxidative drug metabolism and this effect is mediated in part by circulating cytokines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034223     DOI: 10.1023/a:1012007517877

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  Determination of antipyrine in human serum by direct injection restricted access media liquid chromatography.

Authors:  B J Gurley; S Zermatten; D Skelton
Journal:  J Pharm Biomed Anal       Date:  1994-12       Impact factor: 3.935

2.  Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics.

Authors:  Y L Chen; V Le Vraux; A Leneveu; F Dreyfus; A Stheneur; I Florentin; M De Sousa; J P Giroud; B Flouvat; L Chauvelot-Moachon
Journal:  Clin Pharmacol Ther       Date:  1994-06       Impact factor: 6.875

3.  Leukocyte adhesion and hepatic microvascular responses to intestinal ischemia/reperfusion in rats.

Authors:  Y Horie; R Wolf; M Miyasaka; D C Anderson; D N Granger
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

4.  The relationship between the circulating concentrations of interleukin 6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury.

Authors:  E A Pullicino; F Carli; S Poole; B Rafferty; S T Malik; M Elia
Journal:  Lymphokine Res       Date:  1990

5.  Effects of model traumatic injury on hepatic drug metabolism in the rat. I. In vivo antipyrine metabolism.

Authors:  L K Griffeth; G M Rosen; C Tschanz; E J Rauckman
Journal:  Drug Metab Dispos       Date:  1983 Nov-Dec       Impact factor: 3.922

6.  Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.

Authors:  G Engel; U Hofmann; H Heidemann; J Cosme; M Eichelbaum
Journal:  Clin Pharmacol Ther       Date:  1996-06       Impact factor: 6.875

7.  Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein.

Authors:  L M Colletti; S L Kunkel; A Walz; M D Burdick; R G Kunkel; C A Wilke; R M Strieter
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

8.  Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver.

Authors:  E T Morgan; K B Thomas; R Swanson; T Vales; J Hwang; K Wright
Journal:  Biochim Biophys Acta       Date:  1994-10-18

9.  Effect of recombinant human interleukin-1 beta and tumor necrosis factor alpha on liver cytochrome P-450 and serum alpha-1-acid glycoprotein concentrations in the rat.

Authors:  C Poüs; J P Giroud; C Damais; D Raichvarg; L Chauvelot-Moachon
Journal:  Drug Metab Dispos       Date:  1990 Jul-Aug       Impact factor: 3.922

10.  Canine acute phase response: relationship between serum cytokine activity and acute phase protein in dogs.

Authors:  K Yamashita; T Fujinaga; T Miyamoto; M Hagio; Y Izumisawa; T Kotani
Journal:  J Vet Med Sci       Date:  1994-06       Impact factor: 1.267

View more
  5 in total

1.  Pharmacokinetics of oral terbinafine in horses and Greyhound dogs.

Authors:  M M Williams; E G Davis; B KuKanich
Journal:  J Vet Pharmacol Ther       Date:  2011-06       Impact factor: 1.786

2.  Activation of Constitutive Androstane Receptor Ameliorates Renal Ischemia-Reperfusion-Induced Kidney and Liver Injury.

Authors:  You-Jin Choi; Dong Zhou; Anne Caroline S Barbosa; Yongdong Niu; Xiudong Guan; Meishu Xu; Songrong Ren; Thomas D Nolin; Youhua Liu; Wen Xie
Journal:  Mol Pharmacol       Date:  2018-01-19       Impact factor: 4.436

3.  Pharmacokinetics of the cytochrome P-450 substrates phenytoin, theophylline, and diazepam in healthy Greyhound dogs.

Authors:  B KuKanich; J L Nauss
Journal:  J Vet Pharmacol Ther       Date:  2011-06-22       Impact factor: 1.786

Review 4.  Immunopathophysiology of trauma-related acute kidney injury.

Authors:  David A C Messerer; Rebecca Halbgebauer; Bo Nilsson; Hermann Pavenstädt; Peter Radermacher; Markus Huber-Lang
Journal:  Nat Rev Nephrol       Date:  2020-09-21       Impact factor: 28.314

Review 5.  Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolism.

Authors:  John Dixon; Katie Lane; Iain Macphee; Barbara Philips
Journal:  Int J Mol Sci       Date:  2014-02-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.